City View Green Holdings Inc. (CVGR.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.73 Million CAD | 20.15% |
| 2022 | 3.1 Million CAD | -38.09% |
| 2021 | 5.01 Million CAD | 8.53% |
| 2020 | 4.62 Million CAD | -6.59% |
| 2019 | 4.95 Million CAD | 1770.93% |
| 2018 | 264.6 Thousand CAD | 11.66% |
| 2017 | 236.98 Thousand CAD | -56.97% |
| 2016 | 550.69 Thousand CAD | 42.22% |
| 2015 | 387.21 Thousand CAD | 37.71% |
| 2014 | 281.17 Thousand CAD | -13.35% |
| 2013 | 324.5 Thousand CAD | 125.1% |
| 2012 | 144.15 Thousand CAD | -43.56% |
| 2011 | 255.42 Thousand CAD | -73.71% |
| 2010 | 971.68 Thousand CAD | 43.76% |
| 2009 | 675.89 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.92 Million CAD | 3.02% |
| 2024 Q1 | 3.8 Million CAD | 1.97% |
| 2023 FY | 3.73 Million CAD | 20.15% |
| 2023 Q1 | 3.11 Million CAD | 0.3% |
| 2023 Q4 | 3.73 Million CAD | 7.95% |
| 2023 Q2 | 3.22 Million CAD | 3.6% |
| 2023 Q3 | 3.45 Million CAD | 7.11% |
| 2022 Q2 | 5.57 Million CAD | 10.43% |
| 2022 Q4 | 3.1 Million CAD | -45.45% |
| 2022 FY | 3.1 Million CAD | -38.09% |
| 2022 Q1 | 5.04 Million CAD | 0.54% |
| 2022 Q3 | 5.69 Million CAD | 2.21% |
| 2021 Q4 | 5.01 Million CAD | 9.78% |
| 2021 Q3 | 4.57 Million CAD | -0.03% |
| 2021 Q2 | 4.57 Million CAD | -0.98% |
| 2021 FY | 5.01 Million CAD | 8.53% |
| 2021 Q1 | 4.61 Million CAD | -0.12% |
| 2020 FY | 4.62 Million CAD | -6.59% |
| 2020 Q2 | 4.22 Million CAD | -15.85% |
| 2020 Q4 | 4.62 Million CAD | -5.64% |
| 2020 Q3 | 4.9 Million CAD | 15.99% |
| 2020 Q1 | 5.02 Million CAD | 1.42% |
| 2019 Q2 | 3.46 Million CAD | 30.48% |
| 2019 FY | 4.95 Million CAD | 1770.93% |
| 2019 Q3 | 4.75 Million CAD | 37.41% |
| 2019 Q4 | 4.95 Million CAD | 4.09% |
| 2019 Q1 | 2.65 Million CAD | 902.52% |
| 2018 Q1 | 171.72 Thousand CAD | -27.54% |
| 2018 FY | 264.6 Thousand CAD | 11.66% |
| 2018 Q2 | 192.24 Thousand CAD | 11.95% |
| 2018 Q4 | 264.6 Thousand CAD | 28.49% |
| 2018 Q3 | 205.93 Thousand CAD | 7.12% |
| 2017 Q2 | 374.97 Thousand CAD | -35.28% |
| 2017 Q4 | 236.98 Thousand CAD | 35.25% |
| 2017 FY | 236.98 Thousand CAD | -56.97% |
| 2017 Q1 | 579.36 Thousand CAD | 5.21% |
| 2017 Q3 | 175.22 Thousand CAD | -53.27% |
| 2016 FY | 550.69 Thousand CAD | 42.22% |
| 2016 Q3 | 455.57 Thousand CAD | 5.36% |
| 2016 Q1 | 413.67 Thousand CAD | 6.83% |
| 2016 Q4 | 550.69 Thousand CAD | 20.88% |
| 2016 Q2 | 432.39 Thousand CAD | 4.53% |
| 2015 FY | 387.21 Thousand CAD | 37.71% |
| 2015 Q3 | 361.45 Thousand CAD | 12.33% |
| 2015 Q1 | 304.15 Thousand CAD | 8.17% |
| 2015 Q2 | 321.78 Thousand CAD | 5.8% |
| 2015 Q4 | 387.21 Thousand CAD | 7.13% |
| 2014 FY | 281.17 Thousand CAD | -13.35% |
| 2014 Q4 | 281.17 Thousand CAD | -35.25% |
| 2014 Q2 | 436.79 Thousand CAD | 19.21% |
| 2014 Q1 | 366.39 Thousand CAD | 12.91% |
| 2014 Q3 | 434.25 Thousand CAD | -0.58% |
| 2013 Q2 | 132.09 Thousand CAD | -28.02% |
| 2013 Q1 | 183.52 Thousand CAD | 27.31% |
| 2013 Q3 | 138.06 Thousand CAD | 4.52% |
| 2013 FY | 324.5 Thousand CAD | 125.1% |
| 2013 Q4 | 324.5 Thousand CAD | 135.03% |
| 2012 Q1 | 139.03 Thousand CAD | -45.57% |
| 2012 Q4 | 144.15 Thousand CAD | -23.87% |
| 2012 Q2 | 150.16 Thousand CAD | 8.01% |
| 2012 Q3 | 189.34 Thousand CAD | 26.1% |
| 2012 FY | 144.15 Thousand CAD | -43.56% |
| 2011 Q4 | 255.42 Thousand CAD | 13.25% |
| 2011 FY | 255.42 Thousand CAD | -73.71% |
| 2011 Q3 | 225.53 Thousand CAD | -26.56% |
| 2011 Q2 | 307.1 Thousand CAD | -71.99% |
| 2011 Q1 | 1.09 Million CAD | 12.84% |
| 2010 FY | 971.68 Thousand CAD | 43.76% |
| 2010 Q4 | 971.68 Thousand CAD | 0.0% |
| 2009 FY | 675.89 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -27.123% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 73.93% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -693.03% |
| The BC Bud Corporation | 626 Thousand CAD | -496.318% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 43.01% |
| CordovaCann Corp. | 11.29 Million CAD | 66.938% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 56.088% |
| Captor Capital Corp. | 28.76 Million CAD | 87.022% |
| 1CM Inc. | 9.42 Million CAD | 60.387% |
| Global Hemp Group Inc. | 5.82 Million CAD | 35.916% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 82.37% |
| IM Cannabis Corp. | 35.11 Million CAD | 89.369% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -51.77% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 62.97% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -1346.889% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 15.224% |
| Ovation Science Inc. | 728.99 Thousand CAD | -412.073% |
| Pharmadrug Inc. | 2.92 Million CAD | -27.603% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -78.7% |
| RAMM Pharma Corp. | 2.83 Million CAD | -31.651% |
| RIV Capital Inc. | 275.63 Million CAD | 98.646% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -9.666% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 98.976% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 90.067% |
| 1933 Industries Inc. | 23.28 Million CAD | 83.967% |
| Red Light Holland Corp. | 3.82 Million CAD | 2.321% |
| Top Strike Resources Corp. | 20.99 Million CAD | 82.219% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -372.555% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 78.859% |